BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1313 related articles for article (PubMed ID: 16828412)

  • 21. [Pathogenic patterns of genetic predisposition to endocrine tumors].
    Calender A
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1.
    Vidal A; Iglesias MJ; Fernández B; Fonseca E; Cordido F
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):835-8. PubMed ID: 18435740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].
    Saint-André JP; Berger-Dutrieux N; Le Bodic MF; de Micco C; Trouillas J
    Arch Anat Cytol Pathol; 1994; 42(2):77-82. PubMed ID: 7811118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial risk for neuroendocrine tumors.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous lichen amyloidosis associated with multiple endocrine neoplasia type 2A.
    Nunziata V; di Giovanni G; Lettera AM; D'Armiento M; Mancini M
    Henry Ford Hosp Med J; 1989; 37(3-4):144-6. PubMed ID: 2576949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paresthetic notalgia and multiple endocrine neoplasia type 2a (Sipple's syndrome): 3 cases].
    Rivollier C; Emy P; Armingaud P; Buzacoux J; Chadenas D; Legoux A; Estève E
    Ann Dermatol Venereol; 1999; 126(6-7):522-4. PubMed ID: 10495863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple endocrine neoplasms.
    Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):149-63. PubMed ID: 18328987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases.
    Vasen HF; van der Feltz M; Raue F; Kruseman AN; Koppeschaar HP; Pieters G; Seif FJ; Blum WF; Lips CJ
    Arch Intern Med; 1992 Jun; 152(6):1250-2. PubMed ID: 1350898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of the multiple endocrine neoplasia type 2B syndrome.
    Jackson CE; Norum RA
    Henry Ford Hosp Med J; 1992; 40(3-4):232-5. PubMed ID: 1362412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid tumor biology in familial multiple endocrine neoplasia type 1: a model for cancer development.
    Brandi ML
    Henry Ford Hosp Med J; 1992; 40(3-4):181-5. PubMed ID: 1362401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2.
    Nelkin BD; Ball DW; Baylin SB
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):187-213. PubMed ID: 7913025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands.
    Vasen HF; Lamers CB; Lips CJ
    Arch Intern Med; 1989 Dec; 149(12):2717-22. PubMed ID: 2574567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
    Kousseff BG
    Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.
    Bale AE; Norton JA; Wong EL; Fryburg JS; Maton PN; Oldfield EH; Streeten E; Aurbach GD; Brandi ML; Friedman E
    Cancer Res; 1991 Feb; 51(4):1154-7. PubMed ID: 1671755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
    Radford DM; Ashley SW; Wells SA; Gerhard DS
    Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA.
    Tamsen A; Mazur MT
    Arch Pathol Lab Med; 1992 Feb; 116(2):200-3. PubMed ID: 1346363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasia, type 2b, as a cause of megacolon.
    Cope R; Schleinitz PF
    Am J Gastroenterol; 1983 Dec; 78(12):802-5. PubMed ID: 6139955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most common clinical presentations of cutaneous mastocytosis.
    Bulat V; Mihić LL; Situm M; Buljan M; Blajić I; Pusić J
    Acta Clin Croat; 2009 Mar; 48(1):59-64. PubMed ID: 19623875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2.
    Robinson MF; Furst EJ; Nunziata V; Brandi ML; Ferrer JP; Martins Bugalho MJ; di Giovanni G; Smith RJ; Donovan DT; Alford BR
    Henry Ford Hosp Med J; 1992; 40(3-4):249-52. PubMed ID: 1362415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.